Established GLP-1 pathway
Compounded Semaglutide
Compounded medication — not FDA approved. This medication is a compounded preparation, not an FDA-approved, commercially manufactured drug product. The FDA has not reviewed this compounded medication for safety, effectiveness, or quality. Prescription availability is subject to clinical evaluation, applicable law, and pharmacy availability.
A prescription GLP-1 medication that may be considered as part of a clinician-guided weight-management plan.
- Once-weekly formulation may be available
- Clinical eligibility and dosing are individualized
- Nutrition, movement, and follow-up remain important